Literature DB >> 18427212

Multifocal squamous cell carcinomas in an HIV-infected patient with a long-term voriconazole therapy.

Anne Sophie Brunel, Thibaut Fraisse, Catherine Lechiche, Véronique Pinzani, Jean Marc Mauboussin, Albert Sotto.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18427212     DOI: 10.1097/QAD.0b013e3282f706a9

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  6 in total

1.  Catastrophic squamous cell carcinoma in lung transplant patients treated with voriconazole.

Authors:  Sherrif F Ibrahim; Jonathan P Singer; Sarah T Arron
Journal:  Dermatol Surg       Date:  2010-11       Impact factor: 3.398

2.  Long-term voriconazole and skin cancer: is there cause for concern?

Authors:  Cornelius J Clancy; M Hong Nguyen
Journal:  Curr Infect Dis Rep       Date:  2011-12       Impact factor: 3.725

3.  Voriconazole enhances UV-induced DNA damage by inhibiting catalase and promoting oxidative stress.

Authors:  Vivian Lee; Michael D Gober; Hasan Bashir; Conor O'Day; Ian A Blair; Clementina Mesaros; Liwei Weng; Andrew Huang; Aaron Chen; Rachel Tang; Vince Anagnos; JiLon Li; Sophie Roling; Emilija Sagaityte; Andrew Wang; Chenyan Lin; Christopher Yeh; Cem Atillasoy; Christine Marshall; Tzvete Dentchev; Todd Ridky; John T Seykora
Journal:  Exp Dermatol       Date:  2019-10-29       Impact factor: 3.960

4.  High cumulative dose exposure to voriconazole is associated with cutaneous squamous cell carcinoma in lung transplant recipients.

Authors:  Jonathan P Singer; Andreas Boker; Christopher Metchnikoff; Maxwell Binstock; Rebecca Boettger; Jeffrey A Golden; David V Glidden; Sarah T Arron
Journal:  J Heart Lung Transplant       Date:  2012-04-06       Impact factor: 10.247

5.  Multifocal aggressive squamous cell carcinomas induced by prolonged voriconazole therapy: a case report.

Authors:  C Morice; A Acher; N Soufir; M Michel; F Comoz; D Leroy; L Verneuil
Journal:  Case Rep Med       Date:  2010-12-16

6.  Update on the optimal use of voriconazole for invasive fungal infections.

Authors:  Asma Lat; George R Thompson
Journal:  Infect Drug Resist       Date:  2011-02-03       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.